课题基金 / 基金详情

Comparative genomics of protein structure and function

Comparative genomics of protein structure and function
蛋白质结构和功能的比较基因组学
批准号:
9030434
负责人:
OLIVIER LICHTARGE
金额:
$39.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2019-12-31
关键词:
AddressAntimalarialsBenchmarkingBig DataBiologicalBiological AssayCalculiCancer BiologyCancer EtiologyCancer cell lineCell LineCisplatinClinicalClinical MedicineCodeCommunitiesComputational BiologyDataData DiscoveryDatabasesDetectionDiffusionDiseaseDrug TargetingEngineeringEquationEventEvolutionGenesGeneticGenetic screening methodGenomeGenomicsGenotypeGlioblastomaGoalsHead and Neck CancerHead and neck structureHealthHuman GenomeIndividualInvestigationKnowledgeLeadLeftLigandsLinkLiteratureLungMalariaMalignant NeoplasmsMalignant neoplasm of lungMathematicsMeasuresMethodsModelingMolecularMolecular EvolutionMorbidity - disease rateMutagenesisMutationNetwork-basedOncogenesOncogenicPancreasPathway interactionsPatient CarePatientsPatternPharmaceutical PreparationsPhenotypePhosphotransferasesPhylogenetic AnalysisPopulation GeneticsPreclinical Drug EvaluationProblem SolvingProcessProteinsResistanceResolutionRestRoleSeriesSignal TransductionSiteSomatic MutationSpottingsStructureTP53 geneTechniquesTestingThe Cancer Genome AtlasTherapeuticTimeTranslatingTumor Suppressor GenesTumor Suppressor ProteinsTumor TissueValidationVariantWorkartesunatebaseblindcancer cellcancer genomicscancer riskcancer therapycancer typecell typeclinically relevantcohortcomparative genomicscomputer sciencedesigndirect applicationeffective therapyexomeexome sequencingexpression vectorfitnessgene functiongene interactiongenome sequencingguided inquiryhead and neck cancer patienthigh throughput screeningimprovedinnovationinsightinterestmortalitynovelnovel therapeuticspersonalized medicineprotein functionprotein structureprotein structure functionresearch studysmall hairpin RNAstemvector

项目摘要

项目成果

OLIVIER LICHTARGE的其他基金

相似基金

相关文献

中文摘要
翻译
蛋白质结构功能在网络和疾病中的比较基因组学 临床外显子组测序日益频繁,但对患者护理的影响仍然有限 和个性化医疗。阻止这些数据被转换为 治疗计划是,在每个患者中,有害的突变很少,而且看起来很少。 融入了无伤大雅的背景中。因此,致病基因 很难被发现。此外,即使发现了可归罪的基因,它们的功能通常也是 未知。我们现在通过合并两条线的调查来解决这些问题,这两条线都 将生物信息的进化和传播建模为一个平稳的过程。在……里面 蛋白质结构,平滑提高了对进化重要部位的预测, 功能和底物。在网络中,它导致了无需 结构性知识。而且,在基因型-表型关系方面,它导致了 编码突变对适合度的有害作用的方程式。目标1现在提议 细化这个等式,为编码突变的危害打分,以揭示疾病-- 导致基因和途径。鉴于现成的可获得的药物,重点将放在癌症上 来自癌症基因组图谱的外显子组数据。同时,目标2将开发新的和 一般的基于网络的技术来破译感兴趣的蛋白质的作用。目标3将 通过在头部和头部进行测试,通过实验验证致癌基因的选定预测 颈部和肺癌细胞系是否如预期的那样表现为肿瘤抑制因子和 致癌基因。这项工作应该产生创新的、正式的从基因型到表型的分析。 与癌症基因组学直接应用的关系;它将把分子进化和 群体遗传学,同时使临床能够解释基因组变异和 癌症基因的发现决定了发病率和 死亡率,并最终导致新的疗法。
英文摘要
Comparative Genomics of Protein Structure-Function in Networks and Disease Clinical exome sequencing is increasingly frequent but still of limited impact on patient care and personalized medicine. Key difficulties keeping these data from being translated into therapeutic plans are that in each patient harmful mutations are few and seemlessly blended into the vast background of harmless ones. As a result, disease-causing genes are difficult to spot. Also, even when imputable genes are found their functions are typically unknown. We now tackle these problems by merging two lines of investigation that both model the evolution and propagation of biological information as a smooth process. In protein structures, smoothing has improved predictions of evolutionary important sites, functions and substrates. In networks, it has led to function predictions without need of structural knowledge. And, with respect to the genotype-phenotype relationship, it has led to an equation for the harmful action of coding mutations on fitness. Aim 1 now proposes to refine this equation to score the harm of coding mutations in order to uncover disease- causing genes and pathways. The focus will be on cancer given the ready availability of exome data from The Cancer Genome Atlas. In parallel, Aim 2 will develop new and general network-based techniques to decipher the role of proteins of interest. Aim 3 will experimentally validate select predictions of cancer-causing genes by testing in head and neck and lung cancer cell lines whether they behave as expected of tumor suppressors and oncogenes. This work should yield innovative, formal analyses of the genotype to phenotype relationship with direct applications to cancer genomics; it will unite molecular evolution and population genetics, whilst enabling the clinical interpretation of genome variations and the discovery of cancer genes that determine morbidity and mortality and eventually lead to novel therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2022 Human Genetic Variation and Disease GRC and GRS
  • 批准号:
    10468402
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    OLIVIER LICHTARGE
  • 依托单位:
Cognitive Computing of Alzheimer's Disease Genes and Risk
  • 批准号:
    10436879
  • 项目类别:
  • 资助金额:
    $80.0万
  • 财政年份:
    2021
  • 负责人:
    OLIVIER LICHTARGE
  • 依托单位:
Cognitive Computing of Alzheimer's Disease Genes and Risk
  • 批准号:
    10622973
  • 项目类别:
  • 资助金额:
    $27.11万
  • 财政年份:
    2021
  • 负责人:
    OLIVIER LICHTARGE
  • 依托单位:
Cognitive Computing of Alzheimer's Disease Genes and Risk
  • 批准号:
    10669697
  • 项目类别:
  • 资助金额:
    $80.0万
  • 财政年份:
    2021
  • 负责人:
    OLIVIER LICHTARGE
  • 依托单位:
海外基金